Merck (NYSE: MRK) is a top pharmaceutical company coming off a good quarter that shows it is growing its top and bottom lines. Even with that growth, the stock still trades at a fairly modest ...

Let’s set the table for Sunday’s presentation of the lung cancer immunotherapy trial known as HARMONi-2. Last June, Summit Therapeutics created a lot of buzz — and sent its stock surging ...

All Ultiworld Standard and All-Access subscribers will have access to watch the live broadcasts from this year’s Pro Championships, where we will have three games in each broadcasting round. #3 ...

One of those was that it tested using the latest Insider Preview build of Windows, and that this build contained significant optimizations related to branch prediction over extant builds.

Merck (MRK) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock.

To open an image in Preview, double-click on the picture from Finder. Ensure to create a duplicate of your picture before you edit it. That’s because the Preview app automatically saves any changes ...